QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast

Rhea-AI Summary

QIAGEN N.V. (NYSE: QGEN) will release its second quarter 2022 results on Wednesday, July 27, after 22:05 Frankfurt time. A conference call is scheduled for Thursday, July 28, at 15:30 Frankfurt time. Participants can join the call via callback connection, phone, or audio webcast. The company provides innovative solutions for molecular diagnostics and life sciences, serving over 500,000 customers globally. For further details, visit qiagen.com.

Positive

• The upcoming earnings release could indicate strong performance in molecular diagnostics.
• QIAGEN serves over 500,000 customers globally, highlighting its market presence.

Negative

• None.

VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter of 2022.

Press release date / time: Wednesday, July 27, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Thursday, July 28, at 15:30 Frankfurt time / 14:30 London time / 09:30 New York time.

Three options for joining the conference call

Register for call back connection   Click here: Connect Me   Service available 15 minutes before call start

Dial-in by phone     +1 646 828 8075 (U.S.) +44 (0)330 165 4012 (UK) +49 (0)69 22222 5197 (GER)   To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.   Conference ID: 3332305

Access the audio webcast   Click here: Access Webcast

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1556677&tp_key=b55d95ed6e

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of March 31, 2022, QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220707005323/en/

John Gilardi

Vice President, Head of Corporate Communications and Investor Relations

+49 2103 29 11711

+1 240 686 2222

Email: ir@qiagen.com

Phoebe Loh

Senior Director Investor Relations

+49 2103 29 11457

Email: ir@qiagen.com

Source: QIAGEN N.V.

FAQ

When will QIAGEN release its second quarter 2022 results?

QIAGEN will release its second quarter 2022 results on Wednesday, July 27, 2022.

What time is the QIAGEN conference call scheduled?

The QIAGEN conference call is scheduled for Thursday, July 28, 2022, at 15:30 Frankfurt time.

How can I join the QIAGEN conference call?

You can join the QIAGEN conference call via a callback connection, phone dial-in, or by accessing the audio webcast.

What is QIAGEN's stock symbol?

QIAGEN's stock symbol is QGEN, listed on the NYSE.

What services does QIAGEN provide?

QIAGEN provides Sample to Insight solutions for molecular diagnostics and life sciences.